Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: The French Experience

Liver Transplantation

Volumn 20, Issue 12, 2014, Pages 1475-1485

  Compagnon, Philippe ^a   Metzler, Philippe ^b   Samuel, Didier ^c   Camus, Christophe ^b   Niaudet, Patrick ^d   Durrbach, Antoine ^e   Lang, Philippe ^a   Azoulay, Daniel ^a   Duvoux, Christophe ^a   Bayle, Francois ^f   Rivalan, Joseph ^b   Merville, Pierre ^g   Pascal, Gerard ^a   Thervet, Eric ^d   Bensman, Albert ^h   Rostaing, Lionel ⁱ   Deschenes, Georges ^j   Morcet, Jeff ^k   Feray, Cyrille ^a   Boudjema, Karim ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e BICÊTRE HOSPITAL   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g HÔPITAL PELLEGRIN   (France)

^h ARMAND TROUSSEAU HOSPITAL   (France)

ⁱ CHU RANGUEIL   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

^k UNIVERSITÉ DE RENNES 1   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OXALOSIS 1; PERSONAL EXPERIENCE; POSTOPERATIVE PERIOD; RECURRENT DISEASE; SURVIVAL RATE; ADOLESCENT; CHILD; CLINICAL TRIAL; COMPLICATION; FRANCE; HYPEROXALURIA; HYPEROXALURIA, PRIMARY; INFANT; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PRESCHOOL CHILD; REOPERATION; TREATMENT OUTCOME; YOUNG ADULT;

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FRANCE; GRAFT SURVIVAL; HUMANS; HYPEROXALURIA; HYPEROXALURIA, PRIMARY; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84912109147     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24009     Document Type: Article

References (53)

1. Cochat P, Rumnsby G,. Primary hyperoxaluria. N Engl J Med 2013; 369: 649-658.
2. van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA,. Primary hyperoxaluria type 1 in the Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003; 18: 273-279.
3. Danpure CJ,. Primary hyperoxaluria. In:, Scriver CR, Beaudet AL, Sly WS, Valle D,. eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 2001: 3323-3367.
4. Jamieson NV,; for European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005; 25: 282-289.
5. Morgan SH, Purkiss P, Watts RW, Mansell MA,. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 1987; 46: 253-257.
6. Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehi J,. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Pediatr Nephrol 1996; 10: 488-492.
7. Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF,. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 2006; 70: 1642-1648.
8. Cochat P,. Primary hyperoxaluria type 1. Kidney Int 1999; 55: 2533-2547.
9. Wilson RE,. Renal transplantation in congenital and metabolic diseases. A report from the ASC/NIH renal transplant registry. JAMA 1975; 232: 148-153.
10. Watts RW, Veall N, Purkiss P,. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci (Lond) 1984; 66: 591-597.
11. Broyer M, Brunner FP, Brynger H, Dykes SR, Ehrich JH, Fassbinder W, et al. Kidney transplantation in primary oxalosis: data from the EDTA Registry. Nephrol Dial Transplant 1990; 5: 332-336.
12. Scheinman JI, Alexander M, Campbell ED, Chan JC, Latta K, Cochat P,. Transplantation for primary hyperoxaluria in the USA. Nephrol Dial Transplant 1995; 10 (suppl 8): 42-46.
13. Saborio P, Scheinman JI,. Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999; 56: 1094-1100.
14. Watts RW, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K,. Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation. Q J Med 1985; 57: 697-703.
15. Watts RW, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, et al. Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987; 2: 474-475.
16. Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU,. Renal allograft survival in patients with oxalosis. Transplantation 2002; 74: 707-710.
17. Jamieson NV,. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998; 11 (suppl 1): 36-41.
18. Bergstralh EJ, Monico CG, Lieske JC, Herges RM, Langman CB, Hoppe B, Milliner DS; for, IPHR Investigators. Transplantation outcomes in primary hyperoxaluria. Am J Transplant 2010; 10: 2493-2501.
19. Margreiter R, Königsrainer A, Spechtenhauser B, Ladurner R, Pomarolli A, Hörmann C, et al. Our experience with combined liver-kidney transplantation: an update. Transplant Proc 2002; 34: 2491-2492.
20. Bertelli R, Nardo B, Cavallari G, Ercolani G, Lauro A, Neri F, et al. Kidney transplantation combined with other organs in Bologna: an update. Transplant Proc 2008; 40: 1867-1868.
21. Monico CG, Milliner DS,. Combined liver-kidney and kidney-alone transplantation in primary hyperoxaluria. Liver Transpl 2001; 7: 954-963.
22. Ruder H, Otto G, Schutgens RB, Querfeld U, Wanders RJ, Herzog KH, et al. Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1. Eur J Pediatr 1990; 150: 56-58.
23. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
24. Danpure CJ,. Scientific rationale for hepatorenal transplantation in primary hyperoxaluria type 1. In:, Touraine JL, Traeger J, Bétrel H, eds. Transplantation and Clinical Immunology. Amsterdam: Elsevier; 1991: 91-95.
25. Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Cerkauskiene R, et al. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin J Am Soc Nephrol 2012; 7: 458-465.
26. Opelz G, Margreiter R, Döhler B,. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation 2002; 74: 1390-1394.
27. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
28. Kaplan B, Meier-Kriesche HU,. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002; 2: 970-974.
29. Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R,. Survival on dialysis post-kidney transplant failure: results from the Scientific Registry of Transplant Recipients. Am J Kidney Dis 2007; 49: 294-300.
30. Gubenšek J, Arnol M, Ponikvar R, Kovač J, Premru V, Kandus A, et al. Dialysis patients after kidney graft failure: Slovenian experience. Ther Apher Dial 2011; 15: 240-244.
31. Ferhi K, Lakehal M, Avakian R, Bensallah K, Boudjema K, Patard JJ, Guille F,. Combined liver-kidney transplantation: indications and results [in French]. Prog Urol 2008; 18: 245-250.
32. Broyer M, Jouvet P, Niaudet P, Daudon M, Revillon Y,. Management of oxalosis. Kidney Int 1996; 53 (suppl): S93-S98.
33. Onaca N, Sanchez EQ, Melton LB, Netto GJ, Glastad KA, Martin PA, et al. Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation 2005; 80: 421-424.
34. Elias N, Kawai T, Ko DSC, Saidi R, Tolkoff-Rubin N, Wicky S, et al. Native portal vein embolization for persistent hyperoxaluria following kidney and auxiliary partial liver transplantation. Am J Transplant 2013; 13: 2739-2742.
35. Meyburg J, Hoffmann GF,. Liver transplantation for inborn errors of metabolism. Transplantation 2005; 80 (suppl): S135-S137.
36. Leumann E, Hoppe B,. The primary hyperoxalurias. J Am Soc Nephrol 2001; 12: 1986-1993.
37. Trotter JF, Milliner D,. Auxiliary liver transplantation is an ineffective treatment of primary hyperoxaluria. Am J Transplant 2014; 14: 241.
38. Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, et al. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias. Am J Nephrol 2005; 25: 161-170.
39. Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, et al. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type 1. Transplantation 2008; 85: 1253-1260.
40. Morrissey PE, Gordon F, Shaffer D, Madras PN, Silva P, Sahyoun AI, et al. Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg 1998; 4: 363-369.
41. Neumann UP, Lang M, Moldenhauer A, Langrehr JM, Glanemann M, Kahl A, et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001; 71: 1163-1168.
42. Saidman SL, Duquesnoy RJ, Demetris AJ, McCauley J, Ramos H, Mazariegos G, et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994; 2: 61-67.
43. Olausson M, Mjörnstedt L, Nordén G, Rydberg L, Mölne J, Bäckman L, Friman S,. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007; 7: 130-136.
44. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY,. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919-921.
45. van Saase JL, van der Woude FJ, Thorogood J, Hollander AA, van Es LA, Weening JJ, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280-1285.
46. Kemper MJ,. Concurrent or sequential liver and kidney transplantation in children with primary hyperoxaluria type 1? Pediatr Transplant 2005; 9: 693-696.
47. Alkhunaizi AM, Al-Sannaa NA, Raslan WF,. Hyperoxaluria and rapid development of renal failure following a combined liver and kidney transplantation: emphasis on sequential transplantation. JIMD Rep 2012; 3: 91-95.
48. Malla I, Lysy PA, Godefroid N, Smets F, Malaise J, Reding R, Sokal EM,. Two-step transplantation for primary hyperoxaluria: cadaveric liver followed by living donor related kidney transplantation. Pediatr Transplant 2009; 13: 782-784.
49. Mor E, Nesher E, Ben-Ari Z, Weissman I, Shaharabani E, Eizner S, et al. Sequential liver and kidney transplantation from a single living donor in two young adults with primary hyperoxaluria type 1. Liver Transpl 2013; 19: 646-648.
50. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 2012; 27: 1729-1736.
51. Kemper MJ,. The role of preemptive liver transplantation in primary hyperoxaluria type 1. Urol Res 2005; 33: 376-379.
52. Allen AR, Thompson EM, Williams G, Watts RW, Pusey CD,. Selective renal transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 1996; 27: 891-895.
53. van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR,. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004; 66: 746-752.